Costs of psychosis in 2010: Findings from the second Australian National Survey of Psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 48, Issue 2, 2014, Pages 169-182

  Neil, Amanda L ^a   Carr, Vaughan J ^b,c   Mihalopoulos, Cathrine ^d   MacKinnon, Andrew ^e,f   Morgan, Vera A ^g  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Schizophrenia Research Institute   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Australia; cost of illness; psychotic disorders; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

ABSENTEEISM; ACCOMMODATION; ADULT; ARTICLE; AUSTRALIA; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EMPLOYMENT; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PRODUCTIVITY; PSYCHOSIS; YOUNG ADULT; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT;

AUSTRALIA; COST OF ILLNESS; HEALTH CARE COSTS; HEALTH SURVEYS; HUMANS; MENTAL HEALTH SERVICES; PRIVATE SECTOR; PSYCHOTIC DISORDERS;

EID: 84893605803     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413500352     Document Type: Article

References (50)

1. Access Economics (2002) Schizophrenia: Costs. An analysis of the burden of schizophrenia and related suicide in Australia. Melbourne: SANE Australia. Available at: http://www.sane.org/information/research/382-schizophrenia-costs
2. Andrews G. The cost of schizophrenia revisited. Schizophrenia Bulletin. 1991 ; 17: 389-394
3. Andrews G, Hall W, Goldstein G, et al. The economic costs of schizophrenia. Implications for public policy. Archives of General Psychiatry. 1985 ; 42: 537-544
4. Employee earnings, benefits and trade union membership, Australia, August 2010. Canberra: ABS ; 2010a :
5. Labour force, Australia, July 2010. Canberra: ABS ; 2010b :
6. Australian national accounts: national income, expenditure and product, June 2011. Canberra: ABS ; 2011 :
7. Australian crime: facts and figures 2011. Canberra: AIC ; 2012 :
8. Health expenditure Australia 2009-10. Canberra: AIHW ; 2011 :
9. Awad AG, Voruganti LN. The burden of schizophrenia on caregivers: a review. Pharmacoeconomics. 2008 ; 26: 149-162
10. Blanchard JJ, Brown SA, Horan WP, et al. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clinical Psychology Reviews. 2000 ; 20: 207-234
11. Britt H, Miller G, Charles J, et al General practice activity in Australia 2000-01 to 2009-10: 10 year data tables. Canberra: AIHW ; 2010 :
12. Caqueo-Urizar A, Gutierrez-Maldonado J, Miranda-Castillo C. Quality of life in caregivers of patients with schizophrenia: a literature review. Health and Quality of Life Outcomes. 2009 ; 7: 84
13. CarrVNeilAHalpinS. (2002) Costs of psychosis in urban Australia. National Survey of Mental Health and Wellbeing, Bulletin 2. Canberra: Commonwealth Department of Health and Ageing. Available at: http://www.health.gov.au/ internet/main/publishing.nsf/Content/mental-pubs-c-costpsy
14. Carr V, Neil A, Halpin S, et al. Costs of schizophrenia and other psychoses in urban Australia: findings from the low prevalence (psychotic) disorders study. Australian and New Zealand Journal of Psychiatry. 2003 ; 37: 31-40
15. Carr VJ, Lewin TJ, Neil AL, et al. Premorbid, psychosocial and clinical predictors of the costs of schizophrenia and other psychoses. British Journal of Psychiatry. 2004 ; 184: 517-525
16. Chang SM, Cho SJ, Jeon HJ, et al. Economic burden of schizophrenia in South Korea. Journal of Korean Medical Science. 2008 ; 23: 167-175
17. De Hert M, Thys E, Boydens J, et al. Health care expenditure on schizophrenia patients in Belgium. Schizophrenia Bulletin. 1998 ; 24: 519-527
18. Australian Statistics on Medicine 2008. Canberra: Commonwealth of Australia ; 2009 :
19. National Mental Health Report 2010: summary of 15 years of reform in Australia's Mental Health Services under the National Mental Health Strategy 1993-2008. Canberra: Commonwealth of Australia ; 2010 :
20. Australian statistics on medicine 2009. Canberra: Commonwealth of Australia ; 2011 :
21. Fitzgerald PB, Montgomery W, de Castella AR, et al. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics. Australian and New Zealand Journal of Psychiatry. 2007 ; 41: 819-829
22. Foldemo A, Gullberg M, Ek A-C, et al. Quality of life and burden in parents of outpatients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology. 2005 ; 40: 133-138
23. Goeree R, O'Brien B, Goering P, et al. The economic burden of schizophrenia in Canada. Canadian Journal of Psychiatry. 1999 ; 44: 464-472
24. Goetzel RZ, Long SR, Ozminkowski RJ, et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. Journal of Occupational and Environmental Medicine. 2004 ; 46: 398-412
25. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. European Neuropsychopharmacology. 2011 ; 21: 718-779
26. Hall W, Goldstein G, Andrews G, et al. Estimating the economic costs of schizophrenia. Schizophrenia Bulletin. 1985 ; 11: 599-610
27. Hawthorne G, Richardson J, Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Quality of Life Research. 1999 ; 8: 209-224
28. Hilton MF, Scuffham PA, Vecchio N, et al. Using the interaction of mental health symptoms and treatment status to estimate lost employee productivity. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 151-161
29. Hollingworth SA, Lie DC, Siskind DJ, et al. Psychiatric drug prescribing in elderly Australians: time for action. Australian and New Zealand Journal of Psychiatry. 2011 ; 45: 705-708
30. Hollingworth SA, Siskind DJ, Nissen LM, et al. Patterns of antipsychotic medication use in Australia 2002-2007. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 372-377
31. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. Journal of Psychopharmacology. 2010 ; 24: 81-90
32. Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas; An overview of the methods and findings of the study on Low Prevalence Disorders, National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry. 2000 ; 34: 221-236
33. Julious SA. Using confidence intervals around individual means to assess statistical significance between two means. Pharmaceutical Statistics. 2004 ; 3: 217-222
34. Kavanagh DJ, Waghorn G, Jennerc L, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research. 2004 ; 66: 115-124
35. Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophrenia Bulletin. 2004 ; 30: 279-293
36. Kolenikov S. Resampling variance estimation for complex survey data. The Stata Journal. 2011 ; 10: 165-199.
37. Langley-Hawthorne C. Modeling the lifetime costs of treating schizophrenia in Australia. Clinical Therapeutics. 1997 ; 19: 1470-1495
38. Lee S, Keating C, de Castella A, et al Fitting together the pieces: collaborative care models for adults with severe and persistent mental illness. Final project report. Melbourne: Monash Alfred Psychiatry Research Centre, The Alfred and Monash University ; 2010 :
39. Mangalore R, Knapp M. Cost of schizophrenia in England. Journal of Mental Health Policy and Economics. 2007 ; 10: 23-41
40. Morgan VA, Waterreus A, Jablensky A, et al. People living with psychotic illness in 2010: The second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry. 2012 ; 46: 735-752
41. Morgan VA, Watterreus A, Jablensky A, et al People living with psychotic illness 2010. Report on the second Australian national survey. National Mental Health Strategy. Canberra: Department of Health and Ageing ; 2011 :
42. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. British Journal of Psychiatry. 1993 ; 163: 183-189
43. Neil A, Carr V, Mihalopoulos C, et al. What difference a decade? The costs of psychosis in Australia in 2000 and 2010: comparative results from the first and second Australian surveys of psychosis. Australian and New Zealand Journal of Psychiatry. 2014 ;:
44. Pang F. Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics. 2002 ; 20: 75-90
45. Raudino A, Carr VJ, Bush R, et al. Patterns of service utilisation in psychosis: findings of the 2010 Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry. 2014 ;:
46. SegalJE (2006) Cost-of-illness studies - a primer. RTI-UNC Center of Excellence in Health Promotion Economics. Available at: http://www.rti.org/pubs/ coi-primer.pdf
47. Tarricone R. Cost-of-illness analysis. What room in health economics?. Health Policy. 2006 ; 77: 51-63
48. Waghorn G, Saha S, Harvey C, et al. 'Earning and learning' in those with psychotic disorders: the second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry. 2012 ; 46: 774-785
49. ATC classification index with DDDs 2011. Oslo: WHO ; 2010 :
50. Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. Journal of Clinical Psychiatry. 2005 ; 66: 1122-1129